Related Experiment Video
Updated: May 21, 2026

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes
Published on: February 5, 2021
Matrix metalloproteinase 9 contributes to gut microbe homeostasis in a model of infectious colitis
David M Rodrigues1, Andrew J Sousa, Steve P Hawley
1Department of Paediatrics, University of Toronto, 27 Kings College Circle, Toronto, Ontario, Canada. philip.sherman@sickkids.ca
Background:
Inflammatory bowel diseases are associated with increased expression of zinc-dependent Matrix Metalloproteinase 9 (MMP-9). A stark dysregulation of intestinal mucosal homeostasis has been observed in patients with chronic inflammatory bowel diseases. We therefore sought to determine the contribution of MMP-9 to the pathogenesis of Citrobacter rodentium-induced colitis and its effects on gut microbiome homeostasis.
Results:
Wild-type and MMP-9-/- mice aged 5-6 weeks were challenged with C. rodentium by orogastric gavage and sacrificed either 10 or 30 days post-infection. Disease severity was assessed by histological analysis of colonic epithelial hyperplasia and by using an in vivo intestinal permeability assay. Changes in the inflammatory responses were measured by using qPCR, and the composition of the fecal microbiome evaluated with both qPCR and terminal restriction fragment length polymorphism. Activation and localization of MMP-9 to the apical surface of the colonic epithelium in response to C. rodentium infection was demonstrated by both zymography and immunocytochemistry. The pro-inflammatory response to infection, including colonic epithelial cell hyperplasia and barrier dysfunction, was similar, irrespective of genotype. Nonmetric multidimensional scaling of terminal restriction fragments revealed a different fecal microbiome composition and C. rodentium colonization pattern between genotypes, with MMP-9-/- having elevated levels of protective segmented filamentous bacteria and interleukin-17, and lower levels of C. rodentium. MMP-9-/- but not wild-type mice were also protected from reductions in fecal microbial diversity in response to the bacterial enteric infection.
Conclusions:
These results demonstrate that MMP-9 expression in the colon causes alterations in the fecal microbiome and has an impact on the pathogenesis of bacterial-induced colitis in mice.
Insights
Matrix Metalloproteinase 9 (MMP-9) influences gut microbiome balance during bacterial colitis. MMP-9 deficiency protects against disease and preserves microbial diversity in mice, highlighting its role in inflammatory bowel disease pathogenesis.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Inflammatory bowel diseases (IBD) are linked to elevated Matrix Metalloproteinase 9 (MMP-9) expression.
- Intestinal mucosal homeostasis is significantly disrupted in chronic IBD patients.
- The role of MMP-9 in Citrobacter rodentium-induced colitis and gut microbiome disruption requires elucidation.
Purpose of the Study:
- To investigate the contribution of MMP-9 to the pathogenesis of bacterial-induced colitis.
- To assess the impact of MMP-9 on gut microbiome homeostasis during infection.
- To determine if MMP-9 influences host-microbe interactions in the colon.
Main Methods:
- Mice (wild-type and MMP-9-/-) were infected with Citrobacter rodentium.
- Disease severity was evaluated via histology and intestinal permeability assays.
- Inflammatory markers, fecal microbiome composition, and MMP-9 localization were analyzed.
Main Results:
- MMP-9 localized to the colonic epithelium during C. rodentium infection.
- Colitis severity (hyperplasia, barrier dysfunction) was similar between genotypes.
- MMP-9 deficiency led to altered microbiome composition, increased protective bacteria (segmented filamentous bacteria), elevated IL-17, reduced C. rodentium colonization, and preserved microbial diversity.
Conclusions:
- MMP-9 expression in the colon impacts the fecal microbiome.
- MMP-9 plays a role in the pathogenesis of bacterial-induced colitis in mice.
- Targeting MMP-9 may offer therapeutic potential for IBD by modulating the gut microbiome.
More Related Videos
Related Concept Videos
Functions of the Gut Microbiota
Role of Matrix Metalloproteases in Degradation of ECM
A...
Inflammatory Bowel Disease III: Crohn's Disease

